Cleared Traditional

K936067 - ATLAS 1.0 DIAGNOSTIC ULTRASOUND SYSTEM

K936067 is an FDA 510(k) clearance for ATLAS 1.0 DIAGNOSTIC ULTRASOUND SYSTEM, manufactured by Atlantis Diagnostics Intl., Inc.. The device is a Class 2 Radiology device with product code IYN cleared through the Traditional 510(k) pathway after a 675-day FDA review.

K936067 · Atlantis Diagnostics Intl., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1995
Decision
675d
Days
Class 2
Risk

K936067 is an FDA 510(k) clearance for the ATLAS 1.0 DIAGNOSTIC ULTRASOUND SYSTEM. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.

Submitted by Atlantis Diagnostics Intl., Inc. (Bothell, US). The FDA issued a Cleared decision on October 27, 1995 after a review of 675 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Radiology submissions.

View all Atlantis Diagnostics Intl., Inc. devices

FDA 510(k) Submission Details - K936067

510(k) Number K936067 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 1993
Decision Date October 27, 1995
Days to Decision 675 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
568d slower than avg
Panel avg: 107d · This submission: 675d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

IYN Device Classification - Class 2, Special Controls

Product Code IYN System, Imaging, Pulsed Doppler, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYN System, Imaging, Pulsed Doppler, Ultrasonic

All 958
Devices cleared under the same product code (IYN) and FDA review panel - the closest regulatory comparables to K936067.
ALOKA OMNIVIEW DIAGNOSTIC ULTRASOUND SYSTEM
K954022 · Aloka Co., Ltd. · Jan 1996
SSA-340A
K941352 · Toshiba America Medical Systems, In.C · Dec 1995
SIEMENS Q4000
K945072 · Siemens Medical Solutions USA, Inc. · Nov 1995
SIEMENS SONOLINE VERSA
K945773 · Siemens Medical Solutions USA, Inc. · Aug 1995
ULTRASOUND 77030 IMAGING SYSTEM
K944048 · Hewlett-Packard Co. · Mar 1995
MULTI-DOP L
K930458 · Dantec Medical, Inc. · Feb 1995